Search research articles
Contact Us
Filters
Showing results (151-160 of 228) with videos related to
Page
of 23
Sort By:
Cancer Research
|
November 13, 2003
Significance of p63 amplification and overexpression in lung cancer development and prognosis
Pierre P Massion, Peter M Taflan, S M Jamshedur Rahman, et al.
Radiology
|
May 24, 2022
Artificial Intelligence Tool for Assessment of Indeterminate Pulmonary Nodules Detected with CT
Roger Y Kim, Jason L Oke, Lyndsey C Pickup, et al.
Influenza and Other Respiratory Viruses
|
December 21, 2023
Sex differences in COVID-19 symptom severity and trajectories among ambulatory adults
Samuel P Massion, Amanda C Howa, Yuwei Zhu, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 4, 2011
Characterizing the impact of smoking and lung cancer on the airway transcriptome using RNA-Seq
Jennifer Beane, Jessica Vick, Frank Schembri, et al.
Plos One
|
June 24, 2009
Recurrent genomic gains in preinvasive lesions as a biomarker of risk for lung cancer
Pierre P Massion, Yong Zou, Hasmet Uner, et al.
Cancers
|
September 28, 2023
Validation of a Proteomic Signature of Lung Cancer Risk from Bronchial Specimens of Risk-Stratified Individuals
S M Jamshedur Rahman, Sheau-Chiann Chen, Yi-Ting Wang, et al.
Cancer Research
|
July 5, 2002
Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: implications of the phosphatidylinositol 3-kinase pathway
Pierre P Massion, Wen-Lin Kuo, David Stokoe, et al.
The European Respiratory Journal
|
December 11, 2020
Validation of the BRODERS classifier (Benign <i>versus</i> aggRessive nODule Evaluation using Radiomic Stratification), a novel HRCT-based radiomic classifier for indeterminate pulmonary nodules
Fabien Maldonado, Cyril Varghese, Srinivasan Rajagopalan, et al.
Oncotarget
|
February 22, 2018
Complement C4d-specific antibodies for the diagnosis of lung cancer
Daniel Ajona, Marcin Okrój, María J Pajares, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 4, 2015
The RNA binding protein FXR1 is a new driver in the 3q26-29 amplicon and predicts poor prognosis in human cancers
Jun Qian, Mohamed Hassanein, Megan D Hoeksema, et al.
Page
of 23
Search research articles
Search
Showing results (151-160 of 228) with videos related to
Sort By:
Page
of 23
Cancer Research
|
November 13, 2003
Significance of p63 amplification and overexpression in lung cancer development and prognosis
Pierre P Massion, Peter M Taflan, S M Jamshedur Rahman, et al.
Radiology
|
May 24, 2022
Artificial Intelligence Tool for Assessment of Indeterminate Pulmonary Nodules Detected with CT
Roger Y Kim, Jason L Oke, Lyndsey C Pickup, et al.
Influenza and Other Respiratory Viruses
|
December 21, 2023
Sex differences in COVID-19 symptom severity and trajectories among ambulatory adults
Samuel P Massion, Amanda C Howa, Yuwei Zhu, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 4, 2011
Characterizing the impact of smoking and lung cancer on the airway transcriptome using RNA-Seq
Jennifer Beane, Jessica Vick, Frank Schembri, et al.
Plos One
|
June 24, 2009
Recurrent genomic gains in preinvasive lesions as a biomarker of risk for lung cancer
Pierre P Massion, Yong Zou, Hasmet Uner, et al.
Cancers
|
September 28, 2023
Validation of a Proteomic Signature of Lung Cancer Risk from Bronchial Specimens of Risk-Stratified Individuals
S M Jamshedur Rahman, Sheau-Chiann Chen, Yi-Ting Wang, et al.
Cancer Research
|
July 5, 2002
Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: implications of the phosphatidylinositol 3-kinase pathway
Pierre P Massion, Wen-Lin Kuo, David Stokoe, et al.
The European Respiratory Journal
|
December 11, 2020
Validation of the BRODERS classifier (Benign <i>versus</i> aggRessive nODule Evaluation using Radiomic Stratification), a novel HRCT-based radiomic classifier for indeterminate pulmonary nodules
Fabien Maldonado, Cyril Varghese, Srinivasan Rajagopalan, et al.
Oncotarget
|
February 22, 2018
Complement C4d-specific antibodies for the diagnosis of lung cancer
Daniel Ajona, Marcin Okrój, María J Pajares, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 4, 2015
The RNA binding protein FXR1 is a new driver in the 3q26-29 amplicon and predicts poor prognosis in human cancers
Jun Qian, Mohamed Hassanein, Megan D Hoeksema, et al.
Page
of 23